Similar drugsTo uncover
Dosage form: & nbspEa mulch for ingestion.
Pharmacotherapeutic group:laxative
ATX: & nbsp
  • Lactulose in combination with other drugs
  • Pharmacodynamics:

    Lactulose - a synthetic disaccharide consisting of galactose and fructose. There are no hydrolases available for cleavage of the disaccharide to the corresponding monosaccharides. Therefore, when administered orally lactulose practically not metabolized, not absorbed in the stomach and small intestine and unchanged enters the large intestine.

    Under the influence of disaccharidases, the microflora of the large intestine lactulose fermented to monosaccharides, and then to short-chain carboxylic acids. Bacterial transformation of lactulose leads to a decrease in the pH of the intestinal contents, accumulation of short chain fatty acids and increased peristalsis. Short-chain carboxylic acids reduce the pH level in the large intestine, which is accompanied by increased peristalsis and suppression of the growth of proteolytic microflora.

    The rapid adsorption of short-chain fatty acids in the distal parts of the colon improves the absorption of water, sodium and other electrolytes.

    As a result, lactulose has a laxative effect and normalizes the work of the intestine, stimulating the growth and reproduction of normal intestinal microflora (bifidogenic factor).

    Excretion from the body - with intestinal contents, only 3% of the drug is excreted by the kidneys.

    Simethicone - a product with defoaming properties. When ingestion in the digestive tract is not absorbed and eliminated from the body in an unchanged form. Reducing the surface tension at the interface, complicates formation and contributes to the destruction of gas bubbles in the contents of the gastrointestinal tract. The gases released in this way can be absorbed by the walls of the intestine or removed from the body. Reduces the feeling of discomfort in the abdominal region, sometimes accompanying the action of lactulose.

    Contraindications:Galactosemia, intestinal obstruction, fructose intolerance, galactose, lactase deficiency, glucose-galactose malabsorption, hypersensitivity to the drug components.
    Dosing and Administration:

    Inside.

    In the case of a single daily dose, it should be taken at the same time (for example, during breakfast).

    With constipation:

    - children under 1 year old: 5 ml / day.

    - children from 1 to 6 years: 5-10 ml / day;

    - children from 7 to 14 years old: 15 ml / day;

    - Children over 14 years and adults: in the first three days of 15-45 ml / day, then 10-30 ml / day.

    With hepatic coma, precoma, hepatic encephalopathy and hyperammonemia: inside by 30-50 ml 3 times a day, the daily dose can be 90-190 ml; then pass to an individually selected maintenance dose so that the soft stool was maximum 2-3 times a day.

    With intestinal dysbiosis: children older than 7 years and adults: 5 ml 1-2 times a day.

    The dose is selected individually. At reception it is recommended to use a measuring cup.

    During therapy with laxatives, it is recommended to take a sufficient amount of liquid (1.5-2 liters, which is 6-8 glasses) per day.

    Shake before use.

    Side effects:

    In case of application of increased doses of the drug during long-term treatment of hepatic encephalopathy, the patient may develop disturbances in the water-electrolyte balance, which can manifest as weakness, fatigue, dizziness, headache, nausea, myalgia, arrhythmias.

    Special instructions:

    With long-term admission - more than six months, it is recommended to periodically determine the content of electrolytes in the plasma.

    It should be taken into account that the preparation may contain insignificant amounts of bound sugars (for example, lactose, galactose, fructose).

    In the treatment of hepatic coma, high doses of the drug are usually used, and the sugar content in it should be taken into account in patients with diabetes mellitus.

    In the treatment of children laxatives should be used in exceptional cases and under the supervision of a doctor.

    Form release / dosage:

    Emulsion for oral administration.

    Packaging:

    100 ml, 200 ml, 500 ml or 1000 ml of emulsion into white plastic bottles or high-density polyethylene.

    The vials are sealed with screw-on plastic caps or high-density polyethylene caps with a first-opening control ring. A transparent cap of the same material, serving as a measuring cup, is put on top of the lid. The label is labeled on the vial, the instructions for use are under the label.

    Storage conditions:At a temperature of no higher than 25 ° C.
    Keep out of the reach of children.
    Shelf life:
    3 years.
    Terms of leave from pharmacies:On prescription
    Registration number:LP-002009
    Date of registration:20.02.2013 / 04.08.2016
    Expiration Date:20.02.2018
    The owner of the registration certificate:AVVA RUS, OJSC AVVA RUS, OJSC Russia
    Manufacturer: & nbsp
    Representation: & nbspAVVA ENG JSC AVVA ENG JSC Russia
    Information update date: & nbsp09.11.2016
    Illustrated instructions
      Instructions
      Up